Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0801
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2634
    +0.0012 (+0.09%)
     
  • USD/JPY

    151.2030
    -0.1690 (-0.11%)
     
  • Bitcoin USD

    70,096.55
    -622.99 (-0.88%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

COVID-19: Could a vaccine be approved before Election Day?

With three U.S.-based drug manufacturers beginning to show promising results from coronavirus immunization trials, pressure to approve a working vaccine has become a new flash point in the 2020 election. Last week, the Centers for Disease Control and Prevention issued a letter to state governments instructing them to prepare to distribute a vaccine as early as Nov. 1 — two days before Election Day — raising questions on both sides of the aisle that the approval process could become politicized. Yahoo News Medical Contributor Dr. Kavita Patel explains that while it’s technically possible that a vaccine could be approved early by the Food and Drug Administration under an emergency use authorization, it’s unlikely that rapid distribution would follow.

Advertisement